Hutchison China MediTech Limited Company Profile (LON:HCM)

About Hutchison China MediTech Limited

Hutchison China MediTech Limited logoHutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures markets and distributes prescription drugs and consumer health products in China.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: HCM
  • CUSIP:
Key Metrics:
  • Previous Close: $23.78
  • 50 Day Moving Average: $1881.28
  • 200 Day Moving Average: $1936.65
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $1.10B
  • Outstanding Shares: 60,649,000
Additional Links:

Analyst Ratings

Consensus Ratings for Hutchison China MediTech Limited (LON:HCM) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Hutchison China MediTech Limited (LON:HCM)
Show:
DateFirmActionRatingPrice TargetDetails
8/3/2016Beaufort SecuritiesReiterated RatingBuyView Rating Details
8/1/2016Panmure GordonReiterated RatingUnder ReviewView Rating Details
4/11/2016Stifel NicolausInitiated CoverageBuyView Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for Hutchison China MediTech Limited (LON:HCM)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Hutchison China MediTech Limited (LON:HCM)
Current Year EPS Consensus Estimate: $-0.04 EPS

Dividends

Dividend History for Hutchison China MediTech Limited (LON:HCM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Hutchison China MediTech Limited (LON:HCM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/4/2016Nash,ChristopherInsiderBuy42GBX 1,899£797.58
10/20/2015Nash,ChristopherInsiderBuy4,512GBX 2,195£99,038.40
4/21/2015Christopher NashInsiderBuy1,388GBX 1,800£24,984
4/15/2015Simon ToInsiderBuy28,000GBX 1,585£443,800
4/10/2015Simon ToInsiderBuy25,000GBX 1,421.50£355,375
4/7/2015Edith ShihInsiderBuy2,000GBX 1,385£27,700
4/2/2015Simon ToInsiderBuy10,000GBX 1,385£138,500
4/1/2015Edith ShihInsiderBuy15,000GBX 1,365£204,750
3/30/2015Edith ShihInsiderBuy13,000GBX 1,300£169,000
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Hutchison China MediTech Limited (LON:HCM)
DateHeadline
News IconChi-Med: Cancer drug could be a blockbuster (LON:HCM)
www.investorschronicle.co.uk - August 4 at 5:43 PM
biz.yahoo.com logoHalf Year 2016 Hutchison China MediTech Ltd Earnings Release - Time Not Supplied (LON:HCM)
biz.yahoo.com - August 2 at 10:12 AM
capitalcube.com logoHutchison China MediTech Ltd. breached its 50 day moving average in a Bearish Manner : HCM-GB : July 25, 2016 (LON:HCM)
www.capitalcube.com - July 25 at 4:41 AM
uk.finance.yahoo.com logoWhat are the safest places to store your money post-Brexit? (LON:HCM)
uk.finance.yahoo.com - June 27 at 11:27 AM
proactiveinvestors.co.uk logoBeaufort Securities Breakfast Alert: GlaxoSmithKline, Hutchison China Meditech, Imperial Innovations (LON:HCM)
www.proactiveinvestors.co.uk - June 21 at 5:07 PM
breakingfinancenews.com logoHutchison China Meditech Ltd (LON:HCM) price target maintained to GBX0 as issued in a report today by Beaufort Securities (LON:HCM)
breakingfinancenews.com - June 21 at 5:07 PM
stockmarketwire.com logoChi-Med initiation of phase II trial of savolitinib (LON:HCM)
www.stockmarketwire.com - June 20 at 11:37 AM
4-traders.com logoHutchison China MediTech : Savolitinib Global Phase II Trial Initiated in EGFR Mutant Non-Small Cell Lung Cancer (LON:HCM)
www.4-traders.com - June 20 at 11:37 AM
finance.yahoo.com logoHutchison China Meditech Limited: Savolitinib Global Phase II Trial Initiated (LON:HCM)
finance.yahoo.com - June 20 at 11:37 AM
breakingfinancenews.com logoHutchison China Meditech Ltd (LON:HCM) price target held steady to GBX0 as reported today by Panmure Gordon (LON:HCM)
breakingfinancenews.com - June 20 at 11:37 AM
thestreet.com logoHutchison China MediTech Limited Announces Closing Of U.S. Public Offering Of ADSs Raising Approximately US$101 Million On The Nasdaq Stock Market (LON:HCM)
www.thestreet.com - March 22 at 11:01 AM
News IconUpcoming IPO Calendar: This Week's Deals Include 3 Biotechs (HCM, SENS, SBPH) - Money Morning (LON:HCM)
moneymorning.com - March 14 at 2:26 PM
capitalcube.com logoHutchison China MediTech Ltd. breached its 50 day moving average in a Bullish Manner : HCM-GB : March 14, 2016 (LON:HCM)
www.capitalcube.com - March 14 at 4:33 AM
finance.yahoo.com logoHutchison China MediTech Limited Announces Launch of Potential U.S. Public Offering of ADSs (LON:HCM)
au.finance.yahoo.com - March 4 at 1:13 PM
uk.finance.yahoo.com logoChi-Med initiates sulfatinib Phase II clinical trial in thyroid cancer (LON:HCM)
uk.finance.yahoo.com - March 2 at 2:44 AM
biz.yahoo.com logoFull Year 2015 Hutchison China MediTech Ltd Earnings Release - Time Not Supplied (LON:HCM)
biz.yahoo.com - March 1 at 7:07 AM
clintongazette.com logoWere Analysts Bullish Hutchison China MediTech Limited (LON:HCM) This Week? - Clinton Financial (LON:HCM)
www.clintongazette.com - February 26 at 12:02 PM
4-traders.com logoHUTCHISON CHINA MEDITECH LIMITED (LON:HCM)
www.4-traders.com - February 26 at 12:02 PM
News IconHow Many Hutchison China MediTech Limited (LON:HCM)'s Analysts Are Bullish? - Sonoran Weekly Review (LON:HCM)
sonoranweeklyreview.com - February 15 at 2:35 PM
News IconUpdated: Hutchison, Tianjin Bank, GoAir gear up for IPOs (LON:HCM)
www.globalcapital.com - February 15 at 2:35 PM
seekingalpha.com logoWeek In Review: China Resource Plans $1 Billion Hong Kong IPO (LON:HCM)
seekingalpha.com - February 15 at 2:35 PM
News IconIs Hutchison China MediTech Limited a Sell? The Stock Declines Again - Sonoran Weekly Review (LON:HCM)
sonoranweeklyreview.com - February 14 at 1:52 PM
News IconRecent Broker Updates On Hutchison China Meditech Ltd (LON:HCM) - Risers & Fallers (LON:HCM)
www.risersandfallers.com - February 9 at 2:28 PM
publicnow.com logoNotice of Announcement of 2015 Final Results (LON:HCM)
www.publicnow.com - January 29 at 3:15 AM
News IconWhat Do Analysts Think Of Hutchison China Meditech Ltd (LON:HCM) This Week? - Risers & Fallers (LON:HCM)
www.risersandfallers.com - January 26 at 1:30 PM
capitalcube.com logoHutchison China MediTech Ltd. breached its 50 day moving average in a Bearish Manner : January 19, 2016 (LON:HCM)
www.capitalcube.com - January 19 at 4:32 AM
finance.yahoo.com logoChi-Med initiates HMPL-523 Phase I clinical trial in hematological cancer in Australia (LON:HCM)
au.finance.yahoo.com - January 15 at 5:59 AM
capitalcube.com logoHutchison China MediTech Ltd. breached its 50 day moving average in a Bullish Manner : January 8, 2016 (LON:HCM)
www.capitalcube.com - January 8 at 4:30 AM
finance.yahoo.com logoInitiation of Sulfatinib Phase III Registration Study in Neuroendocrine Tumor Patients (LON:HCM)
finance.yahoo.com - December 18 at 2:02 AM
finance.yahoo.com logoUS$105 Million Shanghai Land Compensation Agreement (LON:HCM)
finance.yahoo.com - December 9 at 2:00 AM
finance.yahoo.com logoInitiation of Fruquintinib Phase III Registration Trial in Non-small Cell Lung Cancer (LON:HCM)
finance.yahoo.com - December 8 at 3:03 AM
noodls.com logoResults of Extraordinary General Meeting (LON:HCM)
www.noodls.com - November 10 at 7:16 AM
noodls.com logoDirector's Share Dealing (LON:HCM)
www.noodls.com - November 9 at 3:16 AM
finance.yahoo.com logoChi-Med Initiates Sulfatinib U.S. Clinical Trials (LON:HCM)
finance.yahoo.com - November 6 at 2:00 AM
finance.yahoo.com logoCompletion of Phase I Clinical Trial of Novel Syk Inhibitor HMPL-523 for Autoimmune Diseases in Healthy Volunteers (LON:HCM)
finance.yahoo.com - October 30 at 3:57 AM
finance.yahoo.com logoSulfatinib Clinical Results and Fruquintinib-Savolitinib Combination Preclinical Results to be Presented at the 2015 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference (LON:HCM)
finance.yahoo.com - October 30 at 3:41 AM
noodls.com logoHutchison China MediTech Limited Files Registration Statement for Potential Nasdaq Stock Market Listing (LON:HCM)
www.noodls.com - October 27 at 6:05 AM
finance.yahoo.com logoProof-of-concept Study of Fruquintinib in Non-small Cell Lung Cancer Triggers Milestone Payment (LON:HCM)
finance.yahoo.com - October 23 at 2:46 AM

Social


Last Updated on 8/24/2016 by MarketBeat.com Staff